Log in to save to my catalogue

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_767f2edc0111494e9f0e63b946337fd6

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs

About this item

Full title

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceutics, 2023-05, Vol.15 (6), p.1579

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Pulmonary arterial hypertension (PAH) is a malignant pulmonary vascular syndrome characterized by a progressive increase in pulmonary vascular resistance and pulmonary arterial pressure, which eventually leads to right heart failure and even death. Although the exact mechanism of PAH is not fully understood, pulmonary vasoconstriction, vascular rem...

Alternative Titles

Full title

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_767f2edc0111494e9f0e63b946337fd6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_767f2edc0111494e9f0e63b946337fd6

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics15061579

How to access this item